Sign up to view this video Join Now Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Optimizing CRO and Vendor Selection - Examples from the Field What Matters to Payers: Conversations You Should Start During Phase 2
Sign up to view this video Join Now Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Optimizing CRO and Vendor Selection - Examples from the Field What Matters to Payers: Conversations You Should Start During Phase 2
